Experimental models of acute liver failure

Cover Page

Cite item

Full Text

Abstract

Acute liver failure is a result of massive hepatic necrosis, accompanied by development of hepatic encephalopathy and can cause multiple organ failure with a high risk of death. Treatment of severe acute liver failure remains the most difficult clinical problem. Reproducible experimental model is required to develop new drugs and strategies of treatment of this pathology. Animal model must be close to clinical practice. This review critically examines many of the models described in the literature and discusses the surrounding issues.

References

  1. A rat model for acute hepatic failure / Y. He [et al.] // Hepatobiliary Pancreat. Dis. Int. - 2003. - Vol. 2. - P. 423-425.
  2. Adipose derived mesenchymal stem cells efficiently rescue carbon tetrachloride-induced acute liver failure in mouse / L. Deng [et al.] // Scientific World Journal. - 2014. - Vol. 103. - P. 643.
  3. Allogenic hepatocyte transplantation in immunomodulated Lewis rats with acute liver insufficiency following hepatectomy / M.N. Moharib [et al.] // J Egypt Soc Parasitol. - 2014. - Vol. 44. - P. 221-228.
  4. An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure / M.J. Tunon [et al.] // World J. Gastroenterol. - 2009. - Vol. 15. - P. 3086-3098.
  5. Animal models of fulminant hepatic failure: a critical evaluation / P.N. Newsome [et al.] // Liver Transpl. - 2000. - № 6. - P. 21-31.
  6. Bélanger M. Neurobiological characterization of an azoxymethane mouse model of acute liver failure / M. Bélanger, J. Côté, R. F. Butterworth // Neurochem. Int. - 2006. -Vol. 48. - P. 434-440.
  7. C/EBP homologous protein (CHOP) contributes to hepatocyte death via the promotion of ERO1a signalling in acute liver failure / J. Rao [et al.] // Biochem. J. - 2015. - Vol. 1. - P. 369-378.
  8. Enhanced sedative efficacy and delayed recovery in propofol anesthesia in a rat model of hepatic cirrhosis / X. Chen [et al] // Int. J. Clin. Exp. Med. - 2015. -Vol. 8. - P. 5723-5730.
  9. Hybrid bioartificial liver support in cynomolgus monkeys with D-galactosamine-induced acute liver failure / Z. Zhang [et al.] // World J. Gastroenterol. - 2014. - Vol. 20. - P. 399-406.
  10. Isolation of a Bone Marrow-Derived Stem Cell Line with High Proliferation Potential and Its Application for Preventing Acute Fatal Liver Failure / M. Masahiro [et al.] // STEM. CELLS. - 2007. -Vol. 25. - P. 2855-2863.
  11. Liver regeneration after major hepatectomy. Evaluation of dogs hepatectomy / B.A. Mohamed [et al.] // Tunis Med. - 2005. - Vol. 83. - P. 556.
  12. Российский медико-биологический вестник имени академика И.П. Павлова, № 4, 2015 г.
  13. Martins P.N. Rodent models of partial hepatectomies / P.N. Martins, T.P. Theruvath, P. Neuhaus // Liver Int. -2008. - Vol. 28. - P. 3-11.
  14. Metformin Ameliorates Acetaminophen Hepatotoxicity via Gadd45ß-Dependent Regulation of JNK Signaling in Mice / Y.H. Kim [et al.] // J. Hepatol. - 2015. -Vol. 63. - P. 11.
  15. Models of Drug-induced Liver Injury for Evaluation of Phytotherapeutics and Other Natural Products / H. Jaeschke [et al.] // Food Chem. Toxicol. - 2013. -Vol. 55. - P. 279-289.
  16. Rahman T.M. Animal models of acute hepatic failure / T.M. Rahman, H.J. Hodgson // Int. J. ExpPathol. - 2000. -Vol. 81. - P. 145-157.
  17. Recent advances in management of acute liver failure / C. Panackel [et al.] // Indian J. Crit. Care Med. - 2015. - Vol. 19. - P. 27-33.
  18. SOCS3 expression correlates with severity of inflammation in mouse hepatitis virus strain 3-induced acute liver failure and HBV-ACLF / Y. Li [et al.] // J. Huazhong Univ. Sci. Technolog. Med. Sci. - 2014. - Vol. 3. - P. 348-353.
  19. Sosef M.N. Total hepatectomy model in pigs: revised method for vascular reconstruction using a rigid vascular prosthesis / M.N. Sosef, T.M. van Gulik // EurSurg Res. - 2004. - Vol. 36. - P. 8-12.
  20. Suppressor of cytokine signaling 1 protects mice against concanavalin A-induced hepatitis by inhibiting apoptosis / T. Torisu [et al.] // Hepatology. - 2008. - Vol. 47. - P. 1644-1654.
  21. The liver protective effect of methyl-prednisolone on a new experimental acute-on-chronic liver failure model in rats / C. Hu [et al.] // Dig. Liver Dis. - 2015. - Vol. 46. - P. 928-935.
  22. The value of microsurgery in liver research / M.A. Aller [et al.] // Liver Int. - 2009. - Vol. 29. - P. 1132-1140.
  23. Therapeutic effect of transplanting magnetically labeled bone marrow stromal stem cells in a liver injury rat model with 70%-hepatectomy / Xiao-Wu Chen [et al.] // Med Sci Monit. - 2012. -Vol. 18. - P. 275-382.
  24. Tonsil-derived mesenchymal stem cells alleviate concanavalin A-induced acute liver injury / K.H. Ryu [et al.] // Exp. Cel.l Res. - 2014. - Vol. 1. - P. 143-154.
  25. Weber L.W. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model / L.W. Weber, M. Boll, A. Stampfl // Grit. Rev. Toxicol. - 2003. - Vol. 33. - P. 5-36.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2015 Rudakov V.S., Voskanyan S.E., Eremin I.I., Deev R.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
 


Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).